Celecoxib Targets Breast Cancer Stem Cells by Inhibiting the Synthesis of Prostaglandin E2 and Down-Regulating the WNT Pathway Activity
Oncotarget - United States
doi 10.18632/oncotarget.23250
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 14, 2017
Authors
Publisher
Impact Journals, LLC